News
ALIPANC Online Seminar – Dr. Remy Nicolle, October 15, 2026, 3:00 p.m. CET
Speaker: Dr. Remy Nicolley Institution: Pancreatic Cancer Heterogeneity & Translational Genomics Group | Center for...
Development of an epidemiological score for the early detection of pancreatic cancer
An international team—with significant participation from the PADO group at the ICO and IDIBELL, which includes...
PANTHEIA-SEOM Validates SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer
The multicenter study included 672 patients treated with first-line chemotherapy. A low SIRI score (≤2.3) was...
MNK1, a kinase involved in pancreatic cancer stem cell maintenance
Cancer stem cells (CSCs) are a highly tumorigenic population of pancreatic ductal adenocarcinoma (PDAC) cells that...
A new multi-omic atlas of the human pancreas
The ESPACE consortium presents a comprehensive multi-omic atlas of the human pancreas, profiling more than 4 million...
Next-generation sequencing analysis of pancreatic cancer samples obtained via endoscopy
A recently published study, led by Elisabeth Pando and Teresa Macarulla, demonstrates that tissue obtained through...
5th ALIPANC Charity Gala
5th ALIPANC Charity Gala Friday, November 20, at 8:00 p.m. Real Casino de Madrid C. Alcalá, 15, Centro, 28014 Madrid...
ALIPANC Online Seminar – Dr. Prof. Dieter – July 21, 3:00 p.m. CET
Speaker: Dr. Prof. Dieter Saur Institution: Technical University of Munich Title:“Decoding the PDAC Ecosystem Through...
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Pancreatic cancer carries a dismal prognosis, with a median survival of less than six months following progression on...
A new treatment strategy targets pancreatic cancer and boosts the immune system
A study led by the Hospital del Mar Research Institute and the IIBB-CSIC has identified a new strategy for treating...